Apatinib combined with trastuzumab and albumin-bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti-HER2 TKIs: A case report

Although human epidermal growth factor receptor 2 (HER2)-targeted therapy significantly improves the prognosis of patients with HER2-positive breast cancer, most patients with advanced breast cancer eventually progress due to drug resistance. At present, there is no standard treatment after patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiayi, Chen, Xiao, Guo, Jinfeng, Song, Lin, Mu, Yanxi, Zhao, Han, Du, Caiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827463/
https://www.ncbi.nlm.nih.gov/pubmed/36644147
http://dx.doi.org/10.3892/ol.2022.13642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827463/
https://www.ncbi.nlm.nih.gov/pubmed/36644147
http://dx.doi.org/10.3892/ol.2022.13642

Ejemplares similares